Phase I Safety and Pharmacokinetic Study of ARRY-520 in Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2015
At a glance
- Drugs Filanesib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 05 Apr 2011 Status changed from active, no longer recruiting to completed.
- 05 Apr 2011 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.